CONSIGN study: COVID-19 infection and medicines in pregnancy - a multinational registry based studyFirst published 10/02/2021 Last updated 22/04/2024 EU PAS number: EUPAS39438StudyOngoing
Division of Pharmacoepidemiology & Clinical Pharmacology (PECP), Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht UniversityNetherlands First published: 01/03/2010Last updated 23/05/2024 InstitutionEducational InstitutionENCePP partner
Pharmacoepidemiology and Drug Safety Research Group (PharmaSafe), University of OsloNorway First published: 19/10/2016Last updated 08/11/2016 InstitutionEducational InstitutionENCePP partner
Leibniz Institute for Prevention Research and Epidemiology - BIPSGermany First published: 29/03/2010Last updated 26/02/2024 InstitutionNot-for-profitENCePP partner
Fundació Institut Català de Farmacologia (FICF)Spain First published: 29/03/2010Last updated 17/09/2019 InstitutionEducational InstitutionHospital/Clinic/Other health care facilityNot-for-profitENCePP partner
University Medical Center Utrecht (UMCU)Netherlands First published: 24/11/2021Last updated 22/02/2024 InstitutionEducational InstitutionHospital/Clinic/Other health care facilityENCePP partner
Centre for Pharmacoepidemiology, Karolinska Institutet (CPE-KI)Sweden First published: 24/03/2010Last updated 23/04/2024 InstitutionEducational InstitutionLaboratory/Research/Testing facilityNot-for-profitENCePP partner
RTI Health Solutions (RTI-HS)FranceSpainSwedenUnited KingdomUnited Kingdom (Northern Ireland)United States First published: 21/04/2010Last updated 19/02/2024 InstitutionNot-for-profitENCePP partner
Bordeaux PharmacoEpi, University of BordeauxFrance First published: 07/02/2023Last updated 08/02/2023 InstitutionEducational InstitutionHospital/Clinic/Other health care facilityNot-for-profitENCePP partner
Instituto Aragonés de Ciencias de la Salud (IACS)Spain First published: 01/02/2024Last updated 02/04/2024 InstitutionEducational Institution
The Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO)Spain First published: 01/02/2024Last updated 01/02/2024 Institution
EU Pharmacoepidemiology and Pharmacovigilance (PE&PV) Research NetworkNetherlands First published: 01/02/2024Last updated 22/07/2024 Network